Walleye Capital LLC Abb Vie Inc. Put Options Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $10.5 Million - $12.8 Million	64,300 Added 64.11%	164,600 $32.5 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $20.3 Million - $23.8 Million	-131,400 Reduced 56.71%	100,300 $17.2 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $27.8 Million - $31.7 Million	174,100 Added 302.26%	231,700 $42.2 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $15.2 Million - $17.1 Million	-110,300 Reduced 65.69%	57,600 $8.93 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $12 Million - $13.9 Million	90,000 Added 115.53%	167,900 $25 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $6.03 Million - $7.5 Million	45,500 Added 140.43%	77,900 $10.5 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $2.88 Million - $3.31 Million	19,900 Added 159.2%	32,400 $5.16 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.84 Million - $3.4 Million	-20,500 Reduced 62.12%	12,500 $2.02 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $4.43 Million - $5.08 Million	33,000 New	33,000 $4.43 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $132,066 - $176,724	-1,800 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $25,800 - $39,116	-400 Reduced 18.18%	1,800 $137,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.14 Million - $1.43 Million	-15,800 Reduced 87.78%	2,200 $195,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.12 Million - $1.35 Million	17,800 Added 8900.0%	18,000 $1.36 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $335,070 - $428,298	-5,100 Reduced 96.23%	200 $15,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $408,842 - $481,187	5,300 New	5,300 $427,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account